CTI BioPharma
223 articles about CTI BioPharma
-
CTI BioPharma To Report Third Quarter 2015 Financial Results On November 5, 2015
10/29/2015
-
CTI BioPharma Prices Underwritten Public Offering Of $50 Million Of Convertible Preferred Stock
10/27/2015
-
CTI BioPharma And Fred Hutchinson Cancer Research Center Announce International Research Fellowship To Support Innovative Blood-Related Cancer Research
10/1/2015
-
CTI BioPharma Announces $15.7 Million Registered Direct Offering
9/25/2015
-
CTI BioPharma To Present At The Ladenburg Thalmann 2015 Healthcare Conference
9/24/2015
-
CTI BioPharma To Submit NDA For Pacritinib In Q4 Based Primarily On Data From Single Pivotal Persist-1 Trial
9/23/2015
-
CTI BioPharma Reports Second Quarter 2015 Financial Results
8/7/2015
-
CTI BioPharma To Report Second Quarter 2015 Financial Results On August 6, 2015
7/28/2015
-
CTI BioPharma Appoints Bruce J. Seeley As Executive Vice President And Chief Commercial Officer
7/27/2015
-
CTI BioPharma Release: Tosedostat In Combination With Low Dose Cytarabine Achieves Primary Endpoint In Phase 2 Study In Elderly Patients With AML
6/15/2015
-
CTI BioPharma Release: Tosedostat In Combination With Low Dose Cytarabine Achieves Primary Endpoint In Phase 2 Study In Elderly Patients With AML
6/15/2015
-
CTI BioPharma Release: Pacritinib Phase III Study Shows Positive Results In Patient Reported Outcomes Measuring Quality Of Life In Patients With Myelofibrosis
6/12/2015
-
CTI BioPharma And Baxter International Announce Patient-Reported Outcomes (PROs) From Pacritinib Phase 3 In Patients With Myelofibrosis To Be Presented In Late-Breaking Session At European Hematology Association
6/10/2015
-
CTI BioPharma Amends Loan Agreement
6/10/2015
-
ASCO15: CTI BioPharma Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
6/1/2015
-
CTI BioPharma Reports First Quarter 2015 Financial Results
5/7/2015
-
CTI BioPharma Announces Publication In Blood Of Phase 2 Results Of Pacritinib In Patients With Myelofibrosis
3/16/2015
-
CTI BioPharma Reports Fourth Quarter And Full Year 2014 Financial Results
3/13/2015
-
CTI BioPharma, Baxter International's Blood Cancer Drug Meets Main Goal in Late-Stage Trial
3/9/2015
-
CTI BioPharma To Host Conference Call And Webcast On March 9
3/9/2015